Who is pcma

Are you a recent grad or an event professional early in your career? We apologize for any inconvenience. Please contact:. Registration now open. Be a certified authority on planning and producing effective digital events. PCMA members are part of an influential community of industry leaders that spans the globe. November 11, November 5, We moved our headquarters to Chicago in Wacker Drive. PCMA has 8, professional and student members and a global audience of over , business event stakeholders , across North America, Europe, the Middle East and Asia.

With 17 chapters and activities in 40 countries, we are the global leader in business events. The Foundation funds scholarships for students, faculty and other professionals and recognizes industry accomplishments at the annual Visionary Awards. Convene , a multi-award-winning print magazine started in , is the leading publication in the business events industry with an audited circulation of 36, qualified meeting organizer subscribers.

The revised guidance document was released in early The crisis in the Horn of Africa has been recorded as the most severe emergency of its kind this century. In the wake of the drought, several key reports emerged that highlighted some significant weaknesses in the international response.

Some of the main issues included problems in what and when we analyse. Traditionally, contingency planning and early responses have not been based on clear or predictive livelihood and market analyses.

As a result, agencies do not know what responses are appropriate or adequate. Moreover, traditional response analysis begins with a situation analysis soon after the shock has occurred. Rebate Rule Learn More. Don't Miss the Conference Sessions! Register Today. PBM Industry Principles PBMs have distinct business processes that differentiate them in the market, but PBMs also adhere to stringent accreditation standards, the terms of negotiated contracts, and legal requirements.

Keep Reading. FDA: Biosimilar program a success, but challenges remain November 11, The FDA's biosimilar development program has been a "great success" based on approvals, engagement and increasing uptake in the oncology Learn More Here.

Join the Conversation.